Larvol Delta - ASLAN-Pharmaceuticals-Presents-New-Data-From-Phase-2b-Study-of-Eblasakimab-in-Atopic-Dermatitis-in-Late-Breaker-Presentation-at-32nd-European-Academy-of-Dermatology-and-Venereology-Congress

eblasakimab (ASLAN004) - ASLAN Pharma, Zenyaku Holdings

https://www.globenewswire.com/news-release/2023/10/13/2759991/0/en/ASLAN-Pharmaceuticals-Presents-New-Data-From-Phase-2b-Study-of-Eblasakimab-in-Atopic-Dermatitis-in-Late-Breaker-Presentation-at-32nd-European-Academy-of-Dermatology-and-Venereology.html

Oct 13, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next